Provided by Tiger Trade Technology Pte. Ltd.

Myriad Genetics

5.07
-0.0500-0.98%
Post-market: 5.070.00000.00%16:49 EST
Volume:992.83K
Turnover:5.04M
Market Cap:472.59M
PE:-1.16
High:5.13
Open:5.11
Low:5.03
Close:5.12
52wk High:15.47
52wk Low:3.76
Shares:93.21M
Float Shares:85.72M
Volume Ratio:0.98
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3589
EPS(LYR):-1.4051
ROE:-72.52%
ROA:-5.67%
PB:1.27
PE(LYR):-3.61

Loading ...

Myriad Genetics management to meet with BTIG

TIPRANKS
·
Feb 04

Myriad Genetics to Launch Precise MRD Test for Breast Cancer in March 2026

Reuters
·
Jan 27

Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data

GlobeNewswire
·
Jan 27

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Myriad Genetics (MYGN)

TIPRANKS
·
Jan 13

BRIEF-Myriad Genetics Announces Select Preliminary Fourth Quarter And Full Year 2025 Financial Results And Introduces Full Year 2026 Financial Guidance

Reuters
·
Jan 12

Myriad Genetics Projects 2025 Revenue Between $822 Million and $824 Million

Reuters
·
Jan 12

Myriad Genetics Inc - Full Year 2025 Revenues Expected Between $822 Mln and $824 Mln

THOMSON REUTERS
·
Jan 12

Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
Jan 06

Myriad Genetics Unveils New Data on Precise MRD and MyRisk Tests at 2025 San Antonio Breast Cancer Symposium

Reuters
·
Dec 09, 2025

Myriad Genetics, Clairity, and MagView Launch Integrated AI and Genetic Breast Cancer Risk Platform

Reuters
·
Nov 26, 2025

Myriad Genetics Q3 EPS USD -0.29

Reuters
·
Nov 20, 2025

Myriad Genetics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Nov 12, 2025

Myriad Genetics to Join Wolfe Research and Piper Sandler Healthcare Conferences

Reuters
·
Nov 11, 2025

Stock Track | Myriad Genetics Soars 5% as MyRisk Cancer Test Expands to Include 15 New Actionable Genes

Stock Track
·
Nov 10, 2025

Myriad Genetics Expands MyRisk Hereditary Cancer Test with 15 New Clinically Actionable Genes

Reuters
·
Nov 10, 2025

Myriad Genetics Inc: Adds 15 Clinically Actionable Genes to Myrisk Hereditary Cancer Test

THOMSON REUTERS
·
Nov 10, 2025

Stock Track | Myriad Genetics Soars 5.02% Pre-market on Unveiling of 11 New Genetic Testing Studies

Stock Track
·
Nov 06, 2025

Myriad Genetics Unveils 11 New Genetic Testing Studies at NSGC 2025 Conference

Reuters
·
Nov 06, 2025

Stock Track | Myriad Genetics Soars 5.03% as Wells Fargo Raises Target Price

Stock Track
·
Nov 05, 2025

Stock Track | Myriad Genetics Soars 5% as Wells Fargo Raises Target Price

Stock Track
·
Nov 05, 2025